Long non-coding RNA AGAP2-AS1, functioning as a competitive endogenous RNA, upregulates ANXA11 expression by sponging miR-16-5p and promotes proliferation and metastasis in hepatocellular carcinoma
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Long non-coding RNA AGAP2-AS1, functioning as a competitive endogenous RNA, upregulates ANXA11 expression by sponging miR-16-5p and promotes proliferation and metastasis in hepatocellular carcinoma
Authors
Keywords
-
Journal
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
Volume 38, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-05-14
DOI
10.1186/s13046-019-1188-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- MicroRNA-1468 promotes tumor progression by activating PPAR-γ-mediated AKT signaling in human hepatocellular carcinoma
- (2018) Zhikui Liu et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Downregulation of Annexin A11 (ANXA11) Inhibits Cell Proliferation, Invasion, and Migration via the AKT/GSK-3β Pathway in Gastric Cancer
- (2018) Kelei Hua et al. MEDICAL SCIENCE MONITOR
- Long noncoding AGAP2-AS1 is activated by SP1 and promotes cell proliferation and invasion in gastric cancer
- (2017) Fuzhen Qi et al. Journal of Hematology & Oncology
- Long non-coding RNAs as biomarkers and therapeutic targets: Recent insights into hepatocellular carcinoma
- (2017) Lipeng Qiu et al. LIFE SCIENCES
- Long non-coding RNA CASC2 suppresses epithelial-mesenchymal transition of hepatocellular carcinoma cells through CASC2/miR-367/FBXW7 axis
- (2017) Yufeng Wang et al. Molecular Cancer
- LncRNA-mediated regulation of cell signaling in cancer
- (2017) W-X Peng et al. ONCOGENE
- Upregulated long non-coding RNA AGAP2-AS1 represses LATS2 and KLF2 expression through interacting with EZH2 and LSD1 in non-small-cell lung cancer cells
- (2016) W Li et al. Cell Death & Disease
- Hepatocellular Carcinoma: The Role of Interventional Oncology
- (2016) Matteo Donadon et al. Liver Cancer
- Annexin A11 knockdown inhibits in vitro proliferation and enhances survival of Hca-F cell via Akt2/FoxO1 pathway and MMP-9 expression
- (2015) Shuqing Liu et al. BIOMEDICINE & PHARMACOTHERAPY
- MicroRNA-519a promotes tumor growth by targeting PTEN/PI3K/AKT signaling in hepatocellular carcinoma
- (2015) KANGSHENG TU et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- RIG-I suppresses the migration and invasion of hepatocellular carcinoma cells by regulating MMP9
- (2015) ZHIKUI LIU et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- High-mobility group box 1 has a prognostic role and contributes to epithelial mesenchymal transition in human hepatocellular carcinoma
- (2015) ZHIKUI LIU et al. Molecular Medicine Reports
- Non-coding RNAs: biological functions and applications
- (2014) Baby Santosh et al. CELL BIOCHEMISTRY AND FUNCTION
- Annexin A11 in disease
- (2014) Jiasheng Wang et al. CLINICA CHIMICA ACTA
- Modulation of hypoxia-signaling pathways by extracellular linc-RoR
- (2014) K. Takahashi et al. JOURNAL OF CELL SCIENCE
- Physiological roles of long noncoding RNAs: insight from knockout mice
- (2014) Lingjie Li et al. TRENDS IN CELL BIOLOGY
- Recent progress in understanding, diagnosing, and treating hepatocellular carcinoma
- (2012) Mary Maluccio et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Hepatocellular carcinoma
- (2012) Alejandro Forner et al. LANCET
- Hypoxia-microRNA-16 downregulation induces VEGF expression in anaplastic lymphoma kinase (ALK)-positive anaplastic large-cell lymphomas
- (2011) E Dejean et al. LEUKEMIA
- MicroRNAs in Cancer
- (2009) Ramiro Garzon et al. Annual Review of Medicine
- Long noncoding RNAs: functional surprises from the RNA world
- (2009) J. E. Wilusz et al. GENES & DEVELOPMENT
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started